Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 54Observational 1Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Pancreatic Neoplasms 3Stomach Neoplasms 2Recurrence 2Neoplasms 2Nasopharyngeal Carcinoma 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Neutropenia 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Muscle Neoplasms 1Mesothelioma 1Locally Advanced Pancreatic Adenocarcinoma 1Liver Neoplasms 1Keratosis, Actinic 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Chronic Pain 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Breast Cancer Organoids 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11Liver Transplantation 9atezolizumab 8Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 6regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × Fluorouracil × Clear all
NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡